Neoadjuvant PD-1/PD-L1 combined with CTLA-4 inhibitors for solid malignancies: a systematic review and meta-analysis

BACKGROUND: The effectiveness and safety of neoadjuvant PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors is controversial. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors as neoadjuvant therapy for malig...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shuang, Zheng, Gang, Yang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626778/
https://www.ncbi.nlm.nih.gov/pubmed/37926852
http://dx.doi.org/10.1186/s12957-023-03212-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626778/
https://www.ncbi.nlm.nih.gov/pubmed/37926852
http://dx.doi.org/10.1186/s12957-023-03212-5

Ejemplares similares